Lpath Lands Fast-Track SBIR Grant from the NIH for Traumatic Brain Injury Treatment

[PR Newswire] – SAN DIEGO, May 5, 2014 /PRNewswire/ — Lpath, Inc. (LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the National Institutes of Neurological Diseases and Stroke (NINDS) that it has b more

View todays social media effects on LPTN

View the latest stocks trending across Twitter. Click to view dashboard

See who Lpath is hiring next, click here to view